Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

507
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
507
Sleep Apnea01:21

Sleep Apnea

139
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
139
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

5.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

795
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
795
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

663
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
663
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders.

JAMA network open·2026
Same author

DNA Methylation Variation in Blood Cells may Impact Platelet Function.

TH open : companion journal to thrombosis and haemostasis·2026
Same author

Postresuscitation Cerebral Vasospasm and Capillary Failure After Experimental Asphyxial Cardiac Arrest.

Journal of the American Heart Association·2026
Same author

Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia risk.

Nature communications·2026
Same author

Greater hypoxic burden predicts weaker coordination between brain pulsation and CSF flow on 7T MRI independent of non-hypoxic arousals: Implications for glymphatic activity.

bioRxiv : the preprint server for biology·2026
Same author

"Hypoxic burden" is a concept, not a single variable.

Sleep·2026
Same journal

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank.

Journal of the American Heart Association·2026
Same journal

Sex-Specific Association Between Socioeconomic Status and Stroke Mortality.

Journal of the American Heart Association·2026
Same journal

Social Determinants of Health and Cardiovascular Disease-Related Outcome Disparities Among Breast Cancer Survivors: A Systematic Review.

Journal of the American Heart Association·2026
Same journal

Graded Associations Between Left Ventricular Ejection Fraction Improvement and Cardiorenal Outcomes in Heart Failure With Improved Ejection Fraction.

Journal of the American Heart Association·2026
Same journal

Early Multimodal Motor Training After Stroke Promotes Motor Recovery and Whole-Brain Structural Remodeling.

Journal of the American Heart Association·2026
Same journal

EAT-Lancet Diet, Plasma Metabolites, and Risk of Peripheral Artery Disease: A Prospective Cohort Study.

Journal of the American Heart Association·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2025

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

636

Obstructive Sleep Apnea, Platelet Aggregation, and Cardiovascular Risk.

Zanetta Kovbasyuk1, Jaime Ramos-Cejudo2, Ankit Parekh3

  • 1Healthy Brain Aging and Sleep Center Department of Psychiatry New York University Langone Medical Center New York City NY.

Journal of the American Heart Association
|July 26, 2024
PubMed
Summary
This summary is machine-generated.

Obstructive sleep apnea (OSA) did not show a link with platelet aggregation in the general population. However, in aspirin users, OSA measures were associated with increased platelet aggregation, suggesting a potential mechanism for cardiovascular disease risk.

Keywords:
aspirincardiovascular disease (CVD)obstructive sleep apnea (OSA)platelet aggregationvascular health

More Related Videos

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.7K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

313

Related Experiment Videos

Last Updated: Jun 19, 2025

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

636
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.7K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

313

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Hematology

Background:

  • Obstructive sleep apnea (OSA) and cardiovascular disease (CVD) are linked, but mechanisms are unclear.
  • Platelets are key mediators in CVD risk and thrombosis.
  • Previous research suggested a connection between OSA and platelet activity.

Purpose of the Study:

  • To investigate the association between obstructive sleep apnea (OSA) and platelet aggregation.
  • To explore the relationship between OSA, platelet activity, and cardiovascular disease (CVD) risk factors.

Main Methods:

  • Utilized data from the Sleep Heart and Health Study (SHHS) and Framingham Heart Study (FHS).
  • Employed linear regression models, adjusting for demographic and clinical covariates.
  • Examined interactions with OSA severity (apnea-hypopnea index) and CVD risk factors, including aspirin use.

Main Results:

  • No overall association was found between the apnea-hypopnea index (AHI) and platelet aggregation in the general sample.
  • A significant association between AHI and platelet aggregation was observed in aspirin users.
  • Specific OSA measures, including hypoxic burden and oxygen desaturation index, correlated with platelet aggregation in aspirin users.

Conclusions:

  • Obstructive sleep apnea (OSA) was not associated with platelet aggregation in a general community sample.
  • OSA demonstrated an association with increased platelet aggregation specifically within the aspirin-using subgroup.
  • This suggests that platelet aggregation may be a mediating factor in the adverse cardiovascular effects of OSA, particularly in individuals at risk for CVD.